Annovis Bio Files Patent for Novel Mental Illness Treatment Using Buntanetap
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS), a leading biopharmaceutical company, announced this week the filing of a patent application that covers the use of buntanetap and its analogues …
Annovis Bio Files Patent for Novel Mental Illness Treatment Using Buntanetap Read More